Summary
The semisynthetic ergot derivative lisuride induced dose- and time-dependent hypothermia in rats placed in a cold environment (+4°C). As regards dosage, lisuride was more than 100 times more effective in this test model than bromocriptine. The effect of both drugs could be reduced by pretreatment with the dopamine antagonist haloperidol, which indicated a dopaminergic action of both drugs. In contrast, the hypothermic effect of lisuride could not be impaired by pretreatment with sulpiride, whilst the effects of bromocriptine were clearly antagonized by this drug. This results could be explained by a different affinity of these drugs to the same receptors, or, more likely, by a different mechanism of action by which lisuride and bromocriptine activate dopaminergic systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Calne, D. B., Claveria, L. E., Reid, J. L.: Hypothermic action of bromocriptine. Br. J. Pharmacol. 54, 123–124 (1975)
Cools, R. A., Van Rossum, J. M.: Excitation—mediating and inhibition—mediating dopamine receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological functional and clinical data. Psychopharmacologia (Berl.) 45, 243 (1976)
Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Ungerstedt, U.: Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol. 25, 409 (1973)
Flückiger, E., Doepfner, W., Markó, M., Niederer, W.: Effects of ergot alkaloids on the hypothalamic-pituitary axis. Postgard. Med. J. 52 (Suppl. 1), 57–61 (1976)
Fuxe, K., Fredholm, B. B., Agnati, L., Ögren, S. O., Everitt, B. J., Jonsson, G., Gustafsson, J. A.: Interaction of drugs with central monoamine systems. Pharmacol. (Basel) 16 (Suppl. 1), 99–134 (1978)
Goldstein, M., Bronaugh, R. L., Lew, J. Y., Ohashi, T., Drummon, G. S., Fuxe, K.: Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity. In: Advances in biochemical psychopharmacology, Vol. 16 (E. Costa and L. Gessa, eds.), p. 447. New York: Raven Press 1977
Gräf, K.-J., Neumann, F., Horowski, R.: Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats. Endocrinology 98, 3, 598–605 (1976)
Horowski, R.: Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine. Eur. J. Pharmacol. 51, 157–166 (1978)
Horowski, R., Gräf, K.-J.: Influence of dopaminergic agonists and antagonists on serum prolactin concentration in the rat. Neuroendocrinology 22, 273 (1976)
Horowski, R., Wachtel, H.: Direct dopaminergic action of lisuride hydrogenmaleate, an ergot derivative, in mice. Eur. J. Pharmacol. 36, 373–383 (1976)
Horowski, R., Neumann, F., Gräf, K.-J.: Influence of apomorphine hydrochloride, di-butyryl-apomorphine and lysenyl on plasma prolactin concentrations in the rat. J. Pharm. Pharmacol. 27, 532 (1975)
Johnson, A. M., Loew, D. M., Vigouret, J. M.: Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and l-DOPA. Br. J. Pharmacol. 56, 59 (1976)
Kehr, E.: Effects of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain. Eur. J. Pharmacol. 41, 261–273 (1977)
Kehr, W., Speckenbach, W.: Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 301, 163–169 (1978)
Liuzzi, A., Chiodini, P. G., Oppizzi, G., Botalla, L., Verde, G., de Stefano, L., Colussi, G., Gräf, K.-J., Horowski, R.: Lisuride hydrogen maleate: Evidence for a long lasting dopaminergic activity in humans. J. Clin. Endocrinol. Metab. 46, 196–202 (1978)
Podvalová, I., Dlabač, A.: Lysenyl, a new antiserotonin agent. Res. clin. Stud. Headache, Vol. 33, pp. 325–334. Basel: Karger 1972
Silbergeld, E. K., Adler, J., Calne, D. B.: The roles of presynaptic function and hepatic drug metabolism in the hypothernic actions of two novel dopaminergic agonists. J. Pharm. Pharmacol. 29, 632–635 (1977)
Spano, P. F., Di Chiara, G., Loddo, P., Tonon, G. C., Trabucchi, M.: Dopamine-stimulated adenylate cyclase in rat substantia nigra: Localization and effects of neuroleptics. In: Advances in biochemical psychopharmacology, Vol. 16 (E. Costa and G. L. Gessa, eds.), p. 613. New York: Raven Press 1977
Trabucchi, M., Longoni, L., Fresia, P., Spano, P. F.: Sulpiride: a study of the effect on dopamine receptors in rat neostriatum and limbic forebrain. Life Sci 17, 1551 (1976a)
Trabucchi, M., Spano, P. F., Tonon, G. C., Frattola, L.: Effects of bromocriptine on central dopaminergic neurons. Life Sci. 19, 225 (1976b)
Wachtel, H.: Inhibition of locomotor activity of rats by low doses of different dopamine (DA) receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 302, R59, 236 (1978)
Yehuda, S., Wurtman, R. J.: Release of brain dopamine as the probable mechanism for the hypothermic effect of d-amphetamine. Nature 240, 477 (1972)
Author information
Authors and Affiliations
Additional information
with the technical assistance of Cornelia Riedel
Rights and permissions
About this article
Cite this article
Horowski, R. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics. Naunyn-Schmiedeberg's Arch. Pharmacol. 306, 147–151 (1979). https://doi.org/10.1007/BF00498984
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00498984